Blume Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $165K | Hold |
|
|||||
|
2024
Q4 | $104K | Hold |
|
|||||
|
2024
Q3 | $91.5K | Hold |
|
|||||
|
2024
Q2 | $85.6K | Hold |
|
|||||
|
2024
Q1 | $86.5K | Hold |
|
|||||
|
2023
Q4 | $89.5K | Hold |
|
|||||
|
2023
Q3 | $65.1K | Hold |
|
|||||
|
2023
Q2 | $79.2K | Hold |
|
|||||
|
2023
Q1 | $67.7K | Hold |
|
|||||
|
2022
Q4 | $66.2K | Hold |
|
|||||
|
2022
Q3 | $58K | Hold |
|
|||||
|
2022
Q2 | $71K | Hold |
|
|||||
|
2022
Q1 | $76K | Hold |
|
|||||
|
2021
Q4 | $65K | Hold |
|
|||||
|
2021
Q3 | $47K | Hold |
|
|||||
|
2021
Q2 | $51K | Buy |
|
|||||
|
2021
Q1 | $34K | Hold |
|
|||||
|
2020
Q4 | $32K | Hold |
|
|||||
|
2020
Q3 | $26K | Hold |
|
|||||
|
2020
Q2 | $26K | Hold |
|
|||||
|
2020
Q1 | $15K | Hold |
|
|||||
|
2019
Q4 | $34K | Hold |
|
|||||
|
2019
Q3 | $7K | Hold |
|
|||||
|
2019
Q2 | $13K | Hold |
|
|||||
|
2019
Q1 | $12K | Hold |
|
|||||
|
2018
Q4 | $11K | Hold |
|
|||||
|
2018
Q3 | $22K | Hold |
|
|||||
|
2018
Q2 | $18K | Hold |
|
|||||
|
2018
Q1 | $21K | Hold |
|
|||||
|
2017
Q4 | $14K | Hold |
|
|||||
|
2017
Q3 | $16K | Hold |
|
|||||
|
2017
Q2 | $12K | Hold |
|
|||||
|
2017
Q1 | $16K | Hold |
|
|||||
|
2016
Q4 | $15K | Hold |
|
|||||
|
2016
Q3 | $15K | Hold |
|
|||||
|
2016
Q2 | $39K | Hold |
|
|||||
|
2016
Q1 | $28K | Hold |
|
|||||
|
2015
Q4 | $54K | Hold |
|
|||||
|
2015
Q3 | $40K | Hold |
|
|||||
|
2015
Q2 | $32K | Hold |
|
|||||
|
2015
Q1 | $24K | Hold |
|
|||||
|
2014
Q4 | $18K | Buy |
|